1,470
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Arctiin elevates osteogenic differentiation of MC3T3-E1 cells by modulating cyclin D1

&
Pages 10866-10874 | Received 29 Jan 2022, Accepted 07 Apr 2022, Published online: 27 Apr 2022

References

  • Chai XY, Zhang WC, Chang BY, et al. GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. artif. cell. nanomed. Biotechnol. 2019;47(1):3569–3576.
  • Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155–170.
  • Pavone V, Testa G, Giardina SMC, et al. Pharmacological therapy of osteoporosis: a systematic current review of Literature. Front Pharmacol. 2017;8:803.
  • Wang Q, Wang S, Li XZ, et al. Clinical observation of percutaneous vertebroplasty in the treatment of senile osteoporosis complicated with vertebral compression fractures. Int J Clin Exp Med. 2018;11:7340–7345.
  • Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover - role of the immune system. Nat Rev Endocrinol. 2016;12:518–532.
  • Lee JH, Kim C, Lee J, et al. Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells. Phytomedicine. 2019;55:282–292.
  • Hayashi K, Narutaki K, Nagaoka Y, et al. Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull. 2010;33:1199–1205.
  • Zhou B, Weng G, Huang Z, et al. Arctiin prevents LPS-Induced acute lung injury via inhibition of PI3K/AKT signaling pathway in mice. Inflammation. 2018;41:2129–2135.
  • Chen D, Ye Z, Wang C, et al. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation. Pharmacol Res. 2020;159:104944.
  • Ren Y, Zhang K, Wang J, et al. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-kappaB pathway. Acta Biochim Biophys Sin (Shanghai). 2021;53:201–211.
  • Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4:46–56.
  • Jiang F, Shan H, Pan C, et al. ATP6V1H facilitates osteogenic differentiation in MC3T3-E1 cells via Akt/GSK3beta signaling pathway. Organogenesis. 2019;15:43–54.
  • Chen X, Liu Y, Meng B, et al. Interleukin-20 inhibits the osteogenic differentiation of MC3T3-E1 cells via the GSK3beta/beta-catenin signalling pathway. Arch Oral Biol. 2021;125:105111.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. methods (san diego. Calif.). 2001;25:402–408.
  • Li W, Zhang S, Liu J, et al. Vitamin K2 stimulates MC3T3E1 osteoblast differentiation and mineralization through autophagy induction. Mol Med Rep. 2019;19:3676–3684.
  • Ahn GY, Kim SE, Yun TH, et al. Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment. Biomater Res. 2021;25:28.
  • Hasegawa T, Amizuka N. Bone remodeling and modeling/mini-modeling. Clin Calcium. 2017;27:1713–1722.
  • Jimi E. The role of osteoclastic bone resorption on bone remodeling. Clin Calcium. 2017;27:1689–1695.
  • Putnam SE, Scutt AM, Bicknell K, et al. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res. 2007;21:99–112.
  • An J, Yang H, Zhang Q, et al. Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci. 2016;147:46–58.
  • Wang Q, Xie X, Zhang D, et al. Saxagliptin enhances osteogenic differentiation in MC3T3-E1 cells, dependent on the activation of AMP-activated protein kinase alpha (AMPKalpha)/runt-related transcription factor-2 (Runx-2). Bioengineered. 2022;13:431–439.
  • Ji W, Sun X. Methyl-CpG-binding protein 2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells through regulating forkhead box F1/Wnt/beta-Catenin axis. Bioengineered. 2022;13:583–592.
  • Sun M, Chi G, Li P, et al. Effects of matrix stiffness on the morphology, adhesion, proliferation and osteogenic differentiation of mesenchymal stem cells. Int J Med Sci. 2018;15:257–268.
  • Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19:254–263.
  • Jeong JH, Choi JY. Interrelationship of Runx2 and estrogen pathway in skeletal tissues. BMB Rep. 2011;44:613–618.
  • Shang F, Ming L, Zhou Z, et al. The effect of licochalcone A on cell-aggregates ECM secretion and osteogenic differentiation during bone formation in metaphyseal defects in ovariectomized rats. Biomaterials. 2014;35:2789–2797.
  • Zhang JF, Zhang WB, Dai JW, et al. Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of osteocalcin and Alp. Int J Oral Sci. 2019;11:12.
  • Wang LJ, Cai HQ. Let-7b downgradesCCND1to repress osteogenic proliferation and differentiation ofMC3T3-E1 cells: an implication in osteoporosis. Kaohsiung J Med Sci. 2020;36:775–785.
  • Wang J, Zhao B. MiR-23b-3p functions as a positive factor for osteoporosis progression by targeting CCND1 in MC3T3-E1 cells. In vitro cellular & developmental biology. Animal. 2021;57:324–331.
  • Zhu X, Lin W, Lv C, et al. MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats. J Cell Biochem. 2018;119:8346–8358.
  • Fan C, Jia L, Zheng Y, et al. MiR-34a promotes osteogenic differentiation of human adipose-derived stem cells via the RBP2/NOTCH1/CYCLIN D1 coregulatory network. Stem Cell Reports. 2016;7:236–248.